Editorials

Size of the needle for infant vaccination

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.38971.485683.AB (Published 14 September 2006) Cite this as: BMJ 2006;333:563
  1. Richard Kent Zimmerman (zimmer@pitt.edu), professor
  1. Department of Family Medicine and Clinical Epidemiology, University of Pittsburgh School of Medicine, Fifth Avenue, Pittsburgh, PA 15261

    Longer needles reduce incidence of local reactions

    Vaccine safety is a contentious issue, and parental concern continues.1 An online survey (Harris Poll) in 2004 showed that half of parents are concerned that a child might develop a long term medical condition as a result of vaccination, and 10% are “uncomfortable” having their child vaccinated owing to “health reasons.”2 These parental concerns may be fuelled by the increasing number of websites making serious allegations about vaccine safety.3

    Independent bodies—for example, the US Institute of Medicine—have reviewed the evidence for several vaccines and have generally found them to be safe, albeit with rare risks such as anaphylaxis.4 However, local reactions to vaccines are common—ranging from 6% to 50%, depending on the vaccine, definition of local reaction, and dose number in a series—and this can contribute to the safety concerns expressed by parents. Local reactions can be reduced either by using less reactogenic vaccines, such as …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe